ArticlePDF Available

Anticoagulant activity of Calotropis gigantea leaves

Authors:
  • Dr. Vithalrao Vikhe Patil Foundation's College of Pharmacy, Vilad Ghat, Ahmednagar
  • Padmashree Dr. Vithalrao Vikhe Patil College of Pharmacy, Vilad Ghat, Ahmednagar, MS, India

Abstract and Figures

Calotropia gigantea (Asclcpiadacae) is widely growing plant and has been reported to possess multiple therapeutic properties like anti-pyretic, analgesic, anticonvulsant, anxiolytic, sedative, wound healing and antidiabetic. Chemical investigation of Calotropis gigantea report isolation of different type of photochemicals such as flavonoid, glycoside, terpenoid, steroid etc. However its anti thrombotic property has not been yet elucidated. Hence, in the present study we investigated the anti-thrombotic activity of aqueous and alcoholic extract of leaves of Calotropis gigantea in comparison with standard and normal saline as negative control.
Content may be subject to copyright.
Research J. Pharm. and Tech. 9(9): September2016
1493
ISSN 0974-3618 (Print) www.rjptonline.org
0974-360X (Online)
RESEARCH ARTICLE
Anticoagulant activity of Calotropis gigantea leaves
Jyoti B. Wadekar1*, Ramesh L. Sawant2, Kunal R. Sanklecha2, Amol S. Ghodechor2,
Priyanka B. Sable2, Ganesh D. Barkade2
1Department of Pharmacognosy, Pad. Dr. Vithalrao Vikhe Patil Foundation’s College of Pharmacy, Vilad Ghat,
Ahmednagar 414111, India.
2Department of Pharmaceutical Chemistry and P G Studies, Pad. Dr. Vithalrao Vikhe Patil Foundation’s
College of Pharmacy, Vilad Ghat, Ahmednagar, 414111, India.
*Corresponding Author E-mail: jyotsfriend21@yahoo.com
ABSTRACT:
Calotropia gigantea (Asclcpiadacae) is widely growing plant and has been reported to possess multiple
therapeutic properties like anti-pyretic, analgesic, anticonvulsant, anxiolytic, sedative, wound healing and anti-
diabetic. Chemical investigation of Calotropis gigantea report isolation of different type of photochemicals such
as flavonoid, glycoside, terpenoid, steroid etc. However its anti thrombotic property has not been yet elucidated.
Hence, in the present study we investigated the anti-thrombotic activity of aqueous and alcoholic extract of
leaves of Calotropis gigantea in comparison with standard and normal saline as negative control.
KEYWORDS: Calotropis gigentea, flavonoid, Quick‘s method.
Cardiovascular disease and stroke are the major causes
of morbidity and mortality in high-income countries.
Although many factors contribute to the development of
cardiovascular disease, thrombus formation is the main
trigger event in acute coronary syndrome and stroke.
Injury to the endothelial wall causes platelets to activate
and adhere to the exposed endothelium, leading to
thrombus formation [1].
Herbs and plants have been in use as a source of
therapeutic compounds in traditional medicinal system
since ancient time. Plant-produced compounds are of
interest as sources of safer or more effective substitutes
for synthetically produced antithrombotic agents. Herbal
medicines have been used from the earliest times to the
present day. [2]
Received on 20.01.2016 Modified on 25.01.2016
Accepted on 14.02.2016 © RJPT All right reserved
Research J. Pharm. and Tech 2016; 9(9):1493-1495.
DOI: 10.5958/0974-360X.2016.00290.0
Calotropis species, belonging to the family of
Asclepidaceae in plant kingdom, are the well known
plants throughout the tropical world and they are native
to the tropical and subtropical parts of Asia and Africa
[3]. C. gigantea is a wasteland weed better known as
milkweed, habitat of Asian countries that includes, India,
Indonesia, Malaysia, Philippines, Thailand, Sri Lanka
and China. Tribal people were using this plant parts to
cure several illnesses such as toothache, ear-ache, sprain,
anxiety, pain, epilepsy, diarrhoea and mental disorders
[4]. C. gigantea is scientifically reported for its anti-
Candida activity, cytotoxic activity, antipyretic activity
and wound healing activity.
Figure 1: Calotropis gigantea leaves
Research J. Pharm. and Tech. 9(9): September2016
1494
Phytochemicals present in the various parts of C.
gigantea especially in the leaves are usharin, gigantin,
alpha and beta-calotropeol, beta-amyrin, fatty acids (both
saturated and unsaturated), hydrocarbons, acetates and
the benzoates, a mixture of tetracyclic triterpene
compounds, sterols, giganteol and giganteol are also
found to be present. However cardenolide calotropin, α-
amyrin, β-amyrin, β-sitosterol, α-amyrin
methylbutazone, β-amyrin methylbutazone, α-amyrin
acetate, β-amyrin acetate, lupeol acetate B,
gigantursenyl acetate A, gigantursenyl acetate B,
flavonol glycoside, akundarol, uscharidin, calotropin,
frugoside, calotroposides A to G are responsible for
many of its activities [5]. Current study was focused to
investigate antithrombotic activity of aqueous and
alcoholic extract of C. gigantea leaves.
MATERIALS AND METHODS:
Plant material:
C. gigantea plant was collected from the natural
population growing in the Vilad ghat, Ahmednagar,
India during December 2014. The plant material was
identified at the field using standard keys and
descriptions.
Processing of the plant:
Plant leaves were collected washed and were shade dried
at room temperature. Dried leaves were uniformly
grinded using mechanical grinder. Ten gram of
powdered leaves was soaked in 100 ml of distilled water
and alcohol separately in a conical flask and loaded on
an orbit shaker at a speed of 120 rpm for 24 hours. The
mixture was filtered using Whatman filter paper number
1. The filtrate was concentrated using rotary vacuum
evaporator and dried. Dried aqueous and alcoholic
extracts were collected in an air tight container and
stored at 4°C. The aqueous and alcoholic extracts were
dissolved in sterilized distilled water separately to make
1000 μg/ml stock solution and used to perform
antithrombotic assay [1].
Determination of Prothrombin Time (PT) by Quick‘s
Method:
Pipette out 0.1 ml of plasma in small test tube. Add 0.1
ml of brain thromboplastin and mix. Wait for 2 min and
add pre warmed calcium chloride solution at 37°C, mix
Start the stop watch. Hold the tube in front a source of
light and keep tilting the test tube gently. At first
appearance of fibrin clot stop the watch immediately and
record the time as control reading. Pipette 0.1 ml of
plasma in small test tube; add 0.1 ml of 100 mg/ml test
compound solution. Incubate for 5 min and repeat the
procedure to record the elongation in mean prothrombin
time. [6]
RESULTS AND DISCUSSION:
The aqueous and ethanolic extracts of C. gigantea were
subjected to preliminary phytochemicals screening and
revealed the presence of Alkaloids, Phenolic
compounds/tannins and flavonoids and Sterols. Anti-
coagulant activities of aqueous and ethanolic extracts of
C. gigantea were carried out by Quick’s method and
results are shown in Table 1 and Table 2. The clot lysis
of C. gigantea was found to be increased with the
increase in concentration of the sample. Result shows
that the extracts exhibit moderate anti-coagulant activity.
Literature shows that tannins and flavonoids are
responsible for anti-coagulation [7-8]. Hence the
presence of tannin and flavonoid may contribute the said
activity. Further study is under progress to isolate the
pure component fraction.
Table no. 1: In-vitro anti-coagulant activity of ethanolic extract of
Calotropis gigantia leaves
Sr. No.
Concentration
(mg per dl)
Time
(In sec.)
Mean
1.
100
42
41
40
41.00
2.
250
75
72
77
74.66
3.
500
180
182
180
180.66
Table no. 2: In-vitro anti-coagulant activity of aqueous extract of
Calotropis gigantia leaves
Sr. No.
Concentration
(mg per dl)
Time
(In sec.)
Mean
1.
100
35
35
38
36.00
2.
250
70
70
70
70.33
3.
500
167
160
168
165.00
Table no. 3: In-vitro anti-coagulant activity of Warfarin
Sr. No.
Concentration
(mg per dl)
Time (In sec.)
Mean
1.
100
102
103
103
102.66
CONCLUSION:
From the present study it is evident that aqueous and
ethanolic extract of C. gigantea possess anticoagulant
property. However, in vivo activity of C.gigantea is yet
to be discovered and is in pipeline. By above result, it
can be suggested that the application of the C. gigantea
component may be accessible to the society for the
treatment of cardiovascular diseases.
REFERENCES:
1. Chelucci RC, Dutra LA, Lopes Pires ME, de Melo TR, Bosquesi
PL, Chung MC and Dos Santos JL. Antiplatelet and
antithrombotic activities of non-steroidal anti-inflammatory drugs
containing an N-acyl hydrazone subunit. Molecules. 19(2); 2014:
2089-99.
2. Aarti C. A review on pharmacological and biological properties of
Calotropis gigantea.International Journal of Recent Scientific
Research. 5 (4); 2014: 716-719.
3. Singh S, Singh Sanchita and Singh AP. Phytochemical
investigation of different plant parts of Calotropis gigantea.
International Journal of Scientific and Research Publications.
3 (9); 2013; 1-3.
4. Kumar G, Karthik L and Rao KVB. Antibacterial activity of
aqueous extract of Calotropis gigantea leaves An in vitro study.
Research J. Pharm. and Tech. 9(9): September2016
1495
International Journal of Pharmaceutical Sciences Review and
Research. 4 (2); 2010: 141-144.
5. Kumar PS, Suresh E and Kalavathy S. Review on a potential herb
Calotropis gigantea (L.) R. Br. Scholars Academic Journal of
Pharmacy. 2 (2); 2013:135-143.
6. Sawant RL, Mhaske MS and Wadekar JB. Anticoagulant potential
of schiff bases of 1,3-oxazines, International Journal of
Pharmacy and Pharmaceutical Sciences. 4 (4); 2012: 320-323.
7. Umesh MK, Sanjeevkumar CB, Nayaka HB and Londonkar RL.
Evaluation of in vitro anti-thrombolytic activity and cytotoxicity
potential of Typha angustifolia L leaves extracts. International
Journal of Pharmacy and Pharmaceutical Sciences. 6 (5);
2014: 81-85.
8. Vipin PS, Johannah NM, Menon S , Lawrence L , Raghavamenon
AC and Padikkala J. Antithrombotic and anticoagulant activities of
Desmodium gyrans (DC). Journal of Chemical and
Pharmaceutical Research. 7 (5); 2015: 973-980.
... efficacy in enhancing the bleeding time which correlated well with pharmacokinetic data (Figure 2). Hence, we could conclude that the developed formulation exhibited better anticoagulation activity than plain drug suspension by improving the oral bioavailability of DYP [35][36][37] . ...
Article
Full-text available
Dipyridamole (DYP) is potent drug that prevents the thromboembolic risk. It has been clinically used for chronic treatment of angina pectoris treatment and during the valve replacement. heart valve replacement and long-term angina pectoris treatment and is well absorbed in the stomach with BCS class II drug and low oral bioavailability. The present research investigation was focused on the formulation of matrix tablets of Dipyridamole cocrystals and the evaluation of In vivo anticoagulant activity. The results of the study showed that the formulated matrix tablets of dipyridamole cocrystals showed improved efficacy in comparison with the plain drug by enhancing the pre-compression parameters such as bulk density, tap density, Carr's index, angle of repose and Hausner's ratio and post-compression parameters like thickness and weight variation, hardness and friability, In vitro dissolution parameters. The improved efficacy was confirmed by improvement in the pharmacodynamic parameters such as cutaneous bleeding time and clotting time indicative of enhanced bioavailability of dipyridamole. Thus, it can be concluded that the dipyridamole matrix tablets prove to be more effective in producing the anticoagulant effect in clinical practice as compared to the plain drug resulting in more patient compliance.
... Generally, patients administered with anticoagulants to avoid thrombosis [113] of the deep veins or pulmonary embolism. Nonetheless, due to many problems in anticoagulant treatment, much attention has been paid to the development of an ideal anticoagulant and several attempts have been made in the last year to create a new anticoagulant delivery system. ...
Article
Full-text available
Electrospinning is an advanced emerging technology in a novel drug delivery system. Principally it contributes major application in the pharmaceutical research field due to their versatility of electrospun NFs and productive utilization for the fabrication of drug-loaded fibers. Owing to the tailor-made and tunable properties of NFs such as high porosity, large surface area, superior mechanical properties, small pore size, and simplicity of surface modification, have a significant consideration to researchers. Electrospun nanofibers deal with the exceptional stability and biocompatibility of drug/ bioactive molecules. Besides, the spun process does not only improve the dissolution, solubility of active but also expanded bioavailability of poorly soluble drugs. Therefore, electrospun NFs are accomplished with the targeted, modified, and pH-dependent drug delivery systems. The current review article is an attempt to update the readers about the electrospinning process and spun nanofibers. Besides, this review is covered electrospinning types, parameters that affect the nanofibers, and the composition of nanofibers. Moreover, the key focus of this review is the utilization of electrospun nanofibers in pharmaceutical applications.
Article
The research study designed to investigate the nephroprotective efficiency of Calotropis gigantea stem bark extract. Streptozotocin (60 mg/kg/ i.p) diabetes model was used to evaluate the Nephropathy potential of Calotropis gigantea in animals. After single administration of STZ nephropathic complication develops within four weeks. Nephropathy was assessed by blood urea nitrogen, increasing serum creatinine level, microproteinuria, lipid alteration and high renal oxidative stress. Calotropis gigantea stem bark extract shows prominent nephroprotective effect at high dose (500 mg/kg p.o) as compared to low dose treatment (200 mg/kg p.o) in experimentally induced diabetic nephropathy in rats. The present study indicated the plant having of medicinally significant bioactive constituents that shows tremendous nephroprotective effect. It is concluded that stem bark extract of Calotropis gigantea had a role in diabetes control and impedes the continuation of diabetes-induced experimental nephropathy.
Article
Full-text available
Objective: The aim of this study was to investigate the in vitro thrombolytic activity and cytotoxicity of T angustifolia leaf extract. Methods: An in vitro thrombolytic model was used to evaluate the clot lysis effect of different extracts of T.angustifolia Linn along with Streptokinase as a positive control and distilled water as a negative control. The cytotoxic activity of diffetent extracts of T.angustifolia leaves was evaluated by Brine Shrimp Lethality Bioassay. Results: An in vitro thrombolytic model of aqueous, methanol and chloroform extracts have shown 51.76±2.5%, 58±2.32 and 18±1.84 clot lysis respectively, where as the positive control Streptokinase shown 79.6±1.10 and negative control shown negligible 2.44±0.62. The aqueous, methanol and chloroform extracts have shown brine shrimp lethality with LC50 value of 40μg/ml, 30μg and 104 μg/ml respectively. It was found that aqueous and methanol extracts of T angustifolia possesses potential thrombolytic activity as well as cytotoxicity. Conclusion: The present investigation revealed that the aqueous and methanol extracts of T angustifolia possesses thrombolytic properties as well as cytotoxicity effects and it can be further used for treatment of cardiovascular diseases and cancer.
Article
Full-text available
Nonsteroidal anti-inflammatory drugs (NSAIDs) 1-5 containing an N-acyl hydrazone subunit were prepared and their antiplatelet and antithrombotic activities assessed in vitro and in vivo. Compounds 1-5 inhibited the platelet aggregation induced by adenosine diphosphate and/or arachidonic acid, with inhibition rates of 18.0%-61.1% and 65.9%-87.3%, respectively. Compounds 1 and 5 were the most active compounds, inhibiting adenosine-diphosphate-induced platelet aggregation by 57.2% and 61.1%, respectively. The inhibitory rates for arachidonic-acid-induced platelet aggregation were similar for compound 2 (80.8%) and acetylsalicylic acid (ASA, 80%). After their oral administration to mice, compounds 1, 3, and 5 showed shorter mean bleeding times than ASA. Compounds 1 and 5 also protected against thromboembolic events, with survival rates of 40% and 33%, respectively, compared with 30% for ASA. In conclusion, these results indicate that these novel NSAIDs containing an NAH subunit may offer better antiplatelet and antithrombotic activities than ASA.
Article
Full-text available
Calotropis gigantea is a common wasteland weed and known for various medicinal properties. The aim of the present study was to screen leaves of Calotropis gigantea for the antimicrobial activity against clinical isolates of bacteria. The aqueous extract of the C. gigantea was studied for its antagonistic activity against Staphylococcus aureus, Escherichia coli, Bacillus cereus, Pseudomonas aeruginosa, Micrococcus luteus and Klebsiella pneumoniae. In vitro antimicrobial activity was performed by well diffusion method in MH agar. The extract showed significant effect on the tested organisms. The extract showed maximum zone of inhibition against E. coli (17.6±1.15), whereas, lowest against K. pneumoniae (12.6±1.52). Crude extract showed maximum relative percentage inhibition against B. cereus (188.52 %) and lowest relative percentage inhibition against M. luteus (24.92 %). Minimum Inhibitory Concentration (MIC) was measured by modified agar well diffusion method. Extract showed 50, 25, 6.25, 3.1, 1.5 and 12.5 mg/ml MIC values for S. aureus, K. pneumoniae, B. subtilis, P. aeruginosa, M. luteus and E. coli, respectively.
Article
Antithrombotic, anticoagulant properties of medicinally used Desmodium gyrans (DC)was studied using 70% methanolic extract. Clotting time, prothrombin time, plasma recalcification time and platelet aggregation studies were performed in plasma collected from Desmodium gyrans extract treated male Sprague Dawley rats. Inhibition of lipid peroxidation was assessed in vitro using platelet rich plasma sample. The treatment with extract gave a delay in coagulation by 14.6% in prothrombin time assay. Plasma recalcification time also was enhanced with treatment. Collagen induced platelet aggregation of platelet rich plasma was brought down significantly in dose dependent manner. On treatment lipid peroxidation was brought down by 29.94% compared to the control. © 2015, Journal of Chemical and Pharmaceutical Research. All rights reserved.
Article
A series of Schiff bases of 1, 3-oxazines were synthesized via reaction of 1, 3-oxazine-2-amine with substituted benzaldehyde. The title compounds (3a-3r) were characterized with IR, NMR and screened for their anticoagulant activity by measuring prothombin time by Quick's method. The study revealed that most of the synthesized compounds exhibited significant anticoagulant activity amongst which compound 3c, 3f, 3g, 3j, 3o and 3p were found to be most active.
A review on pharmacological and biological properties of Calotropis gigantea
  • C Aarti
Aarti C. A review on pharmacological and biological properties of Calotropis gigantea. International Journal of Recent Scientific Research. 5 (4); 2014: 716-719.
Phytochemical investigation of different plant parts of Calotropis gigantea
  • S Singh
  • Singh Sanchita
  • A P Singh
Singh S, Singh Sanchita and Singh AP. Phytochemical investigation of different plant parts of Calotropis gigantea. International Journal of Scientific and Research Publications. 3 (9); 2013; 1-3.
Review on a potential herb Calotropis gigantea
  • P S Kumar
  • E Suresh
  • S Kalavathy
Kumar PS, Suresh E and Kalavathy S. Review on a potential herb Calotropis gigantea (L.) R. Br. Scholars Academic Journal of Pharmacy. 2 (2); 2013:135-143.